News
ELAT
21.32
0.00%
0.00
APVMA Approves Elanco’s Advocate Ultra Chew for Dogs in Australia
Reuters · 3d ago
Elanco Management Joins BofA 2026 Animal Health Summit Fireside Chat
Reuters · 4d ago
U.S. RESEARCH ROUNDUP-EBay, Huntsman, Palo Alto
Reuters · 4d ago
ELANCO ANIMAL HEALTH INC <ELAN.N>: JP MORGAN RAISES TARGET PRICE TO $28 FROM $24
Reuters · 4d ago
ELANCO ANIMAL HEALTH INC - DAVID HOOVER RETIRES AS CHAIRMAN OF ELANCO BOARD
Reuters · 02/13 14:25
Elanco Animal Health Announces Board Departures as Hoover and Kochevar Step Down
Reuters · 02/13 13:08
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, JPMorgan, Intel
Reuters · 01/22 18:42
BUZZ-U.S. STOCKS ON THE MOVE-Autodesk, Teledyne, Alphabet
Reuters · 01/22 16:02
BUZZ-U.S. STOCKS ON THE MOVE- Medicus Pharma, Lam Research, Applied Digital
Reuters · 01/22 14:11
Elanco Animal Health Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results
Reuters · 01/22 13:01
BUZZ-U.S. STOCKS ON THE MOVE-Micron, Rambus, GE Aerospace
Reuters · 01/22 12:10
BUZZ-Elanco Animal Health shares rise after Piper Sandler upgrades to 'overweight'
Reuters · 01/22 10:15
ELANCO ANIMAL HEALTH INC <ELAN.N>: PIPER SANDLER RAISES TARGET PRICE TO $30 FROM $24
Reuters · 01/22 08:34
ELANCO ANIMAL HEALTH INC <ELAN.N>: PIPER SANDLER RAISES TO OVERWEIGHT FROM NEUTRAL
Reuters · 01/22 08:34
Elanco Animal Health to Participate in J.P. Morgan Healthcare Conference
Reuters · 01/06 13:02
USDA Approves Elanco's Befrena for Canine Allergic and Atopic Dermatitis
Reuters · 12/31/2025 19:00
ELANCO ANIMAL HEALTH INC - CONTINUES TO EXPECTS TO LAUNCH BEFRENA IN FIRST HALF OF 2026
Reuters · 12/31/2025 19:00
BUZZ-Animal health stocks mostly roar back in 2025, barring laggard Zoetis
Reuters · 12/31/2025 12:58
FDA Grants Conditional Approval to Elanco's Credelio Quattro-CA1 for Treatment of New World Screwworm in Dogs
Reuters · 12/18/2025 13:43
ELANCO'S CREDELIO QUATTRO™-CA1 (LOTILANER, MOXIDECTIN, PRAZIQUANTEL, AND PYRANTEL CHEWABLE TABLETS) RECEIVES FIRST FDA CONDITIONAL APPROVAL FOR TREATMENT OF NEW WORLD SCREWWORM IN DOGS
Reuters · 12/18/2025 13:43
More
Webull provides a variety of real-time ELAT stock news. You can receive the latest news about Elanco Animal Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About ELAT
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its parasiticide portfolios in the pet health sector include species and formulations, with products that protect pets from worms, fleas and ticks. Its over-the-counter treatments include Seresto, Advantage, Advantix, Advocate, Credelio, Interceptor Plus and Trifexis. Its farm animal portfolio consists of products designed to prevent, control and treat health challenges primarily focused on cattle. Its products include medicated feed additives, antibiotics, vaccines, such as Rumensin and Baytril. Its poultry products are Maxiban and others